Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02403739
Other study ID # 686881
Secondary ID Z001
Status Completed
Phase N/A
First received March 19, 2015
Last updated June 19, 2017
Start date March 2015
Est. completion date May 2016

Study information

Verified date June 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Simulated growth data will be shown to clinicians in two formats - (1) as weight vs.age charts, (2) as weight Z-score vs. age charts. Clinicians will be asked to identify whether growth is too fast, too slow, or normal. The test will take a total of 10 minutes.


Description:

BACKGROUND Optimization of growth is essential for preterm infants. Optimum post-natal growth has been shown to improve long-term developmental outcomes. Close monitoring of weight gain, including early identification of growth faltering, is an important part of appropriate nutritional management in the Neonatal Intensive Care Unit.

Current practices in neonatal intensive care units involve the routine use of growth charts to track and identify patterns in the growth of preterm infants. Perhaps the most popular growth chart in use today is the Fenton Growth Chart. To interpret this chart, a patient's growth curve is plotted over a set of standard curves (typically representing the 10th, 25th, 50th, 75th and 90th weight-for-age centile). The curves are then visually compared to identify patterns in growth (adequate, slow, or catch-up growth). Patterns in neonatal growth may be subtle and current growth curves may be prone to misinterpretation. This may be due to biases inherent in the human visual perception system, including the difficulty in visually estimating slopes and angles between two curves.

An improved growth chart would use horizontal lines rather than curves, and would have no oblique lines to skew visual perception. Z-score growth charts accomplish this. Z-score growth charts are created using the same standardized data used to create the Fenton Growth Chart. Z-scores represent standard deviation scores. Rather than using a set of standard curves to represent average healthy growth, the z-score chart uses a single horizontal line. This allows for easier comparison when plotting a patient's weights over time. Such charts may lead to more accurate interpretation of overall growth patterns.

This study will compares the accuracy of interpretation of the growth data using the same standard - once as presented using traditional weight-vs.-age charts, and again using the same data displayed as Z-score vs age charts.

INCLUSION AND EXCLUSION CRITERIA

It will include UC Davis Medical Center healthcare personnel who interpret growth charts for preterm infants. This may include the following:

- Attending Neonatologists

- Attending Pediatricians

- Dietitians

- Medical Students

- Neonatal Fellows

- Neonatal Nurse Practitioners

- Pediatric Residents This study will exclude persons who do not routinely interpret growth charts for preterm infants as part of their clinical responsibilities.

NUMBER OF SUBJECTS This will be a single center study. The sample size needed for 80% power with an alpha of 0.05 is estimated to be at least 40. Approaching 45-50 providers should be sufficient to achieve this number.

RECRUITMENT METHODS Healthcare providers who meet the inclusion criteria will be approached on an individual and/or group basis. We may attempt to hold a meeting (perhaps at lunch time) when volunteers may participate in the study.

COMPENSATION TO SUBJECTS If there is a meeting held at lunchtime for volunteers to participate in this study, there may be a small lunch provided (such as sandwiches, pizza and/or soft drinks). When subjects are approached on an individual basis, there will be no compensation offered.

STUDY TIMELINES

- The duration of an individual subject's participation in the study: less than one hour.

- The duration anticipated to enroll all study subjects: three to six months.

- The estimated date for the investigators to complete this study (complete primary analyses): Less than six months

STUDY ENDPOINTS Primary endpoint: after 40-50 persons have completed the study. Primary or secondary safety endpoints: there are no foreseeable safety issues with participating in this questionnaire based study.

PROCEDURES INVOLVED

Study design:

- Study subjects will be asked to view a brief presentation. This will describe Fenton Preterm and Z-score growth charts, and review how they are interpreted.

- Hypothetical (i.e. dummy data) for 10-20 infants will be displayed both as weigh vs. age charts and as Z-score vs age charts. The data will consist of 2 points approximately 1-2w apart. Subjects will be asked whether the growth between the two points is "normal" (paralleling centile lines on the weight vs age charts, or horizontal on the Z-score vs age charts), "slower than normal" or "faster than normal"). The order of presentation of the charts will be randomized

- Subjects will record their interpretation of the growth data on a sheet (marking a box for "normal", "faster than normal" or "slower than normal".

- At the end of the presentation subjects will be asked to record their level of training (medical student, resident, fellow, NNP, neonatal attending, or other) on the sheet.

- A space will be provided on the datasheet for subjects to record any impression of the charts they may wish to share.

- Subjects will be provided unmarked envelopes to put their datasheets in to return them to the investigators (so investigators will be unaware of the answers, or whether the subjects completed the datasheet)


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 2016
Est. primary completion date November 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

It will include UC Davis Medical Center healthcare personnel who interpret growth charts for preterm infants. This may include the following:

- Attending Neonatologists

- Attending Pediatricians

- Dietitians

- Medical Students

- Neonatal Fellows

- Neonatal Nurse Practitioners

- Pediatric Residents This study will exclude persons who do not routinely interpret growth charts for preterm infants as part of their clinical responsibilities.

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No Intervention
No Intervention

Locations

Country Name City State
United States UC Davis Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correct answers Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT02249754 - Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania N/A
Completed NCT02438774 - Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania N/A
Recruiting NCT03053687 - Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy N/A
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT02716935 - Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants N/A
Completed NCT02236468 - Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso N/A
Not yet recruiting NCT01494779 - Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A. Phase 1
Completed NCT05946928 - EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
Recruiting NCT03290235 - Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children Phase 4
Completed NCT02259166 - Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania N/A
Recruiting NCT06071403 - The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
Completed NCT05640596 - Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
Completed NCT04633135 - Research on Emissions, Air Quality, Climate and Cooking Technologies in Northern Ghana N/A
Completed NCT00174278 - Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary Phase 3
Recruiting NCT05518188 - Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) Phase 1/Phase 2
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT00813189 - Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid Phase 3